Organization | L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.

L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. Report issue

For profit Phase 3

Founded: SCANDICCI Italy (1892)

Organization Overview

First Clinical Trial

2014

NCT01980498

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Alternative names

L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.

Active Ingredients

Drugs in Phase 3 Trials (1)

fentanyl (Innovar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Head and Neck Neoplasms (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 1
# of Trial APIs: 1